Allogene Therapeutics, Inc. (ALLO): Price and Financial Metrics

Allogene Therapeutics, Inc. (ALLO)

Today's Latest Price: $18.89 USD

0.21 (-1.10%)

Updated Apr 3 12:00am

Add ALLO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ALLO Daily Price Range
ALLO 52-Week Price Range

ALLO Stock Price Chart More Charts

ALLO Price/Volume Stats

Current price $18.89 52-week high $33.80
Prev. close $19.10 52-week low $17.43
Day low $18.71 Volume 482,800
Day high $19.90 Avg. volume 662,125
50-day MA $22.87 Dividend yield N/A
200-day MA $26.53 Market Cap 2.36B

Allogene Therapeutics, Inc. (ALLO) Company Bio

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the research, development, and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is developing UCART19, a CAR T cell product candidate targeting CD19, which is in clinical trials in patients with R/R B-cell precursor acute lymphoblastic leukemia; ALLO-501, an allogeneic anti-CD19 CAR T cell product candidate for the treatment of patients with R/R non-Hodgkin lymphoma; ALLO-715, an allogeneic CAR T cell product candidate for the treatment of patients with R/R multiple myeloma; and ALLO-647, an anti-CD52 monoclonal antibody for use as a lymphodepleting agent. It is also developing ALLO-819, an anti-Flt3 product candidate for the treatment of acute myeloid leukemia; CD70 for the treatment of renal cell cancer; and DLL3 for the treatment of small cell lung cancer. The company was founded in 2017 and is based in South San Francisco, California.

ALLO Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ALLO Latest Social Stream

Loading social stream, please wait...

View Full ALLO Social Stream

ALLO Price Returns

1-mo -30.06%
3-mo -27.40%
6-mo -25.16%
1-year -32.46%
3-year N/A
5-year N/A
YTD -27.29%
2019 -3.53%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7369 seconds.